Italy is the second exposed country worldwide, after China, and Lombardia is the most affected region in Italy, with more than half of the national cases, with 13% of whom being healthcare professionals.
The Clinica Pediatrica Università degli Studi di Milano Bicocca is a general pediatric and hematology oncology and transplant center embedded within the designated COVID-19 general Hospital San Gerardo in Monza, located in Lombardia, Italy. Preventive and control measures specifically undertaken to cope with the emergency within hemato-oncology, transplant, and outpatient unit in the pediatric department have been described.
BSA, 1mg/mL |
|||
22070005-2 | Glycomatrix | 50 mL | EUR 39.2 |
BSA, 1mg/mL |
|||
22070005-3 | Glycomatrix | 1 mL | EUR 13.17 |
CD8(C8/1035), 1mg/mL |
|||
BNUM1035-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD25(143-13), 1mg/mL |
|||
BNUM0297-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD53(161-2), 1mg/mL |
|||
BNUM0324-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD26(202-36), 1mg/mL |
|||
BNUM0888-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD16(C16/1045), 1mg/mL |
|||
BNUM1045-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
pS2(TFF1/1091), 1mg/mL |
|||
BNUM1091-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD43(SPN/1094), 1mg/mL |
|||
BNUM1094-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD86(C86/1146), 1mg/mL |
|||
BNUM1146-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD28 (C28/1636), 1mg/mL |
|||
BNUM1636-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD71(TFRC/1059), 1mg/mL |
|||
BNUM1059-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TOX3(TOX3/1123), 1mg/mL |
|||
BNUM1123-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TOX3(TOX3/1124), 1mg/mL |
|||
BNUM1124-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD74(CLIP/1133), 1mg/mL |
|||
BNUM1133-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD71(TFRC/1149), 1mg/mL |
|||
BNUM1149-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
IDH1(IDH1/1152), 1mg/mL |
|||
BNUM1152-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PAX6(PAX6/1166), 1mg/mL |
|||
BNUM1166-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
EMI1(EMI1/1176), 1mg/mL |
|||
BNUM1176-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PAX7 (PAX7/1187), 1mg/mL |
|||
BNUM1187-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD79a (IGA/1406), 1mg/mL |
|||
BNUM1406-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BTLA(BTLA/1528), 1mg/mL |
|||
BNUM1528-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD1c(CD1C/1603), 1mg/mL |
|||
BNUM1603-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
ROR2(ROR2/1911), 1mg/mL |
|||
BNUM1911-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
ROR2(ROR2/1912), 1mg/mL |
|||
BNUM1912-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MDM2(MDM2/2414), 1mg/mL |
|||
BNUM2414-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
NRF1(NRF1/2608), 1mg/mL |
|||
BNUM2608-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
NRF1(NRF1/2609), 1mg/mL |
|||
BNUM2609-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MTF1(MTF1/2649), 1mg/mL |
|||
BNUM2649-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Tal1(TAL1/2707), 1mg/mL |
|||
BNUM2707-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Tal1(TAL1/3146), 1mg/mL |
|||
BNUM3146-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Collagen 1mg/ml |
|||
ABP-COL-T1 | Abpcorp | 3 x 0,5ml vials | EUR 97.2 |
Carrier RNA 1mg |
|||
CR000001 | Geneaid Biotech | each | EUR 3 |
CD70(TNFS7/1026), 1mg/mL |
|||
BNUM1026-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34(HPCA1/1171), 1mg/mL |
|||
BNUM1171-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MMP9 (rMMP9/1769), 1mg/mL |
|||
BNUM2176-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
NKX2.8(NKX28/2547), 1mg/mL |
|||
BNUM2547-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
NKX2.8(NKX28/2548), 1mg/mL |
|||
BNUM2548-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
S100B(S100B/1012), 1mg/mL |
|||
BNUM1012-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SOX10(SOX10/1074), 1mg/mL |
|||
BNUM1017-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Cdc20(CDC20/1102), 1mg/mL |
|||
BNUM1102-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
STAT2(STAT2/2650), 1mg/mL |
|||
BNUM2650-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Decorin(DCN/3523), 1mg/mL |
|||
BNUM3523-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Nucleolin(364-5), 1mg/mL |
|||
BNUM0527-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD41a(ITGA2B/1036), 1mg/mL |
|||
BNUM1036-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RA(PTPRC/1131), 1mg/mL |
|||
BNUM1131-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RB(PTPRC/1132), 1mg/mL |
|||
BNUM1132-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RB(PTPRC/1147), 1mg/mL |
|||
BNUM1147-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RA(PTPRC/1148), 1mg/mL |
|||
BNUM1148-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Gastrin(GAST/2631), 1mg/mL |
|||
BNUM2631-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Gastrin(GAST/2632), 1mg/mL |
|||
BNUM2632-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Gastrin(GAST/2633), 1mg/mL |
|||
BNUM2633-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Gastrin(GAST/2634), 1mg/mL |
|||
BNUM2634-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Gastrin(GAST/2635), 1mg/mL |
|||
BNUM2635-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
S100A9(S100A9/1011), 1mg/mL |
|||
BNUM1011-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TRIM29(TRIM29/1041), 1mg/mL |
|||
BNUM1041-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TRIM29(TRIM29/1042), 1mg/mL |
|||
BNUM1042-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
S100A9(S100A9/1075), 1mg/mL |
|||
BNUM1075-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TGFalpha(TGFA/1119), 1mg/mL |
|||
BNUM1119-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CELA3B(CELA3B/1218), 1mg/mL |
|||
BNUM1218-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SREBP1(SREBP1/1578), 1mg/mL |
|||
BNUM1578-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SREBP2(SREBP2/1579), 1mg/mL |
|||
BNUM1579-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
STAT5B(STAT5B/2611), 1mg/mL |
|||
BNUM2611-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
STAT5B(STAT5B/2657), 1mg/mL |
|||
BNUM2657-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Fibronectin(2755-8), 1mg/mL |
|||
BNUM0091-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Fibronectin(FN1/2949), 1mg/mL |
|||
BNUM2949-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Calprotectin(CPT/1028), 1mg/mL |
|||
BNUM1028-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Calpastatin(CAST/1550), 1mg/mL |
|||
BNUM1550-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD4(C4/206), 1mg/mL |
|||
BNUM0206-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD6(C6/372), 1mg/mL |
|||
BNUM0372-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD8(C8/468), 1mg/mL |
|||
BNUM0468-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD5(C5/473), 1mg/mL |
|||
BNUM0473-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD7(C7/511), 1mg/mL |
|||
BNUM0511-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
bcl-2(124), 1mg/mL |
|||
BNUM0530-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
p53(TRP/816), 1mg/mL |
|||
BNUM0816-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
p53(TRP/817), 1mg/mL |
|||
BNUM0817-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Bax(BAX/962), 1mg/mL |
|||
BNUM0962-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
NKX2.2(NX2/294), 1mg/mL |
|||
BNUM0294-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD13(APN/514), 1mg/mL |
|||
BNUM0514-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD2(LFA2/600), 1mg/mL |
|||
BNUM0600-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD68(C68/684), 1mg/mL |
|||
BNUM0684-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD1a(C1A/711), 1mg/mL |
|||
BNUM0711-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD43(SPN/839), 1mg/mL |
|||
BNUM0839-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MUC2(MLP/842), 1mg/mL |
|||
BNUM0842-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD14(MDA/929), 1mg/mL |
|||
BNUM0929-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD47(IAP/964), 1mg/mL |
|||
BNUM0964-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD30(CD30/412), 1mg/mL |
|||
BNUM0412-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PAX7(PAX7/497), 1mg/mL |
|||
BNUM0497-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PAX6(PAX6/498), 1mg/mL |
|||
BNUM0498-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD79a(IGA/515), 1mg/mL |
|||
BNUM0515-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD63(MX-49.129.5), 1mg/mL |
|||
BNUM0525-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD14(LPSR/553), 1mg/mL |
|||
BNUM0553-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD14(LPSR/654), 1mg/mL |
|||
BNUM0654-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
PCNA(PCNA/694), 1mg/mL |
|||
BNUM0694-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD79a(IGA/764), 1mg/mL |
|||
BNUM0764-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD20(IGEL/773), 1mg/mL |
|||
BNUM0773-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD74(CLIP/813), 1mg/mL |
|||
BNUM0813-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD99(MIC2/877), 1mg/mL |
|||
BNUM0877-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD26(DPP4/910), 1mg/mL |
|||
BNUM0910-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD14(LPSR/927), 1mg/mL |
|||
BNUM0927-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD147(BSG/963), 1mg/mL |
|||
BNUM0963-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD117(KIT/982), 1mg/mL |
|||
BNUM0982-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD117(KIT/983), 1mg/mL |
|||
BNUM0983-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD19(CVID3/155), 1mg/mL |
|||
BNUM0155-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FOXP3(FXP3/197), 1mg/mL |
|||
BNUM0197-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD19(CVID3/366), 1mg/mL |
|||
BNUM0366-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD117(C117/370), 1mg/mL |
|||
BNUM0370-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD25(IL2RA/423), 1mg/mL |
|||
BNUM0423-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD19(CVID3/429), 1mg/mL |
|||
BNUM0429-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Moesin(MSN/491), 1mg/mL |
|||
BNUM0491-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD11b(C11b/660), 1mg/mL |
|||
BNUM0660-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD34(HPCA1/763), 1mg/mL |
|||
BNUM0763-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
GFAP(ASTRO/789), 1mg/mL |
|||
BNUM0789-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD68(LAMP4/824), 1mg/mL |
|||
BNUM0824-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD63(LAMP3/968), 1mg/mL |
|||
BNUM0968-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
ZAP70(ZAP70/528), 1mg/mL |
|||
BNUM0528-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FGF23(FGF23/638), 1mg/mL |
|||
BNUM0638-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HSP60(GROEL/730), 1mg/mL |
|||
BNUM0730-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HSP27(HSPB1/774), 1mg/mL |
|||
BNUM0774-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HSP60(HSPD1/780), 1mg/mL |
|||
BNUM0780-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RO(T200/797), 1mg/mL |
|||
BNUM0797-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HSP60(HSPD1/875), 1mg/mL |
|||
BNUM0875-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SOX10(SOX10/991), 1mg/mL |
|||
BNUM0991-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SOX10(SOX10/992), 1mg/mL |
|||
BNUM0992-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Moesin (rMSN/492), 1mg/mL |
|||
BNUM2307-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Insulin(IRDN/794), 1mg/mL |
|||
BNUM0794-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Insulin(IRDN/805), 1mg/mL |
|||
BNUM0805-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD45RA(PTPRC/818), 1mg/mL |
|||
BNUM0818-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Nucleolin(NCL/902), 1mg/mL |
|||
BNUM0902-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Bax(2D2), 1mg/mL |
|||
BNUM0004-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD2(BH1), 1mg/mL |
|||
BNUM0320-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
pS2(GE2), 1mg/mL |
|||
BNUM0677-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD7(124.1D1), 1mg/mL |
|||
BNUM1046-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD32(7.3), 1mg/mL |
|||
BNUM1078-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD32(8.7), 1mg/mL |
|||
BNUM1079-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD64(10.1), 1mg/mL |
|||
BNUM2846-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD55 (DAF)(143-30), 1mg/mL |
|||
BNUM0179-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Tyrosinase(OCA1/812), 1mg/mL |
|||
BNUM0812-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Involucrin(IVRN/827), 1mg/mL |
|||
BNUM0827-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD66 (CEA)(C66/1009), 1mg/mL |
|||
BNUM1009-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
IGF-1(IGF1/1020), 1mg/mL |
|||
BNUM1020-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD66 (CEA)(C66/1030), 1mg/mL |
|||
BNUM1030-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
MyoD1(5.8A), 1mg/mL |
|||
BNUM0191-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD36(1E8.), 1mg/mL |
|||
BNUM0314-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD38(AT1), 1mg/mL |
|||
BNUM0430-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD68(KP1), 1mg/mL |
|||
BNUM0512-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD1a(O10), 1mg/mL |
|||
BNUM0667-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
HSP27(G3.1), 1mg/mL |
|||
BNUM0861-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD38(AT2), 1mg/mL |
|||
BNUM1086-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Histone H1(1415--1), 1mg/mL |
|||
BNUM0580-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
FSH beta(FSHb/1062), 1mg/mL |
|||
BNUM1062-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
VEGF-A(VEGF/1063), 1mg/mL |
|||
BNUM1063-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Mucin 3(MUC3/1154), 1mg/mL |
|||
BNUM1154-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD262 / DR5(DR5/3381), 1mg/mL |
|||
BNUM3381-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
TNF alpha(TNFA/1172), 1mg/mL |
|||
BNUM1172-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SUMO-1(SUMO1/1188), 1mg/mL |
|||
BNUM1188-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
SUMO-2(SUMO2/1199), 1mg/mL |
|||
BNUM1199-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
EZH2 / KMT6(EZH2/2536), 1mg/mL |
|||
BNUM2536-50 | Biotium | 1uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
S100B(4C4.9), 1mg/mL |
|||
BNUM0143-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD13(WM15), 1mg/mL |
|||
BNUM0153-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD20(B9E9), 1mg/mL |
|||
BNUM0160-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD33(WM53), 1mg/mL |
|||
BNUM0166-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD70(BU69), 1mg/mL |
|||
BNUM0187-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD74(BU45), 1mg/mL |
|||
BNUM0189-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD86(BU63), 1mg/mL |
|||
BNUM0193-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD3e(RIV9), 1mg/mL |
|||
BNUM0322-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD8(RIV11), 1mg/mL |
|||
BNUM0333-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD28(CB28), 1mg/mL |
|||
BNUM0384-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD147(8D6), 1mg/mL |
|||
BNUM0424-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
CD6(3F7B5), 1mg/mL |
|||
BNUM0428-50 | Biotium | 50uL | EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Preliminary COVID-19 experiences with the first Italian pediatric hemato-oncology patients are reported. The few available data regarding pediatrics and specifically hemato-oncological patients are discussed.
The purpose of this report is to share pediatric hemato-oncology issues encountered in the first few weeks of the COVID-19 outbreak in Italy and to alert healthcare professionals worldwide to be prepared accordingly.